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ABSTRACT

Miller, Charman L. DNP. Miami Valley College of Nursing and Health, Wright State
University, 2015. Improving Compliance with Clinical Practice Guidelines to Reduce
Urinary Tract Infections in Long Term Care.

This evidence-based clinical change project addressed the clinical problem trigger of
increased rates of urinary tract infections and related unplanned discharges in a rural
Ohio nursing center. The clinical change involved the implementation of a nursing-driven
protocol for suspected Urinary Tract Infection (sUTI) based on the American Medical
Director’s Association Clinical Practice Guideline: Common Infections. An
interdisciplinary team approach to evidence-based clinical change was utilized through
use of the Iowa Model of Evidence-based Practice to Promote Quality Care. Both the
process and the intervention were evaluated through analysis of outcome data including
rates of urinary tract infection, compliance with the guideline recommendations,
measurement of adverse outcomes, and evaluation of policy. The sUTI protocol was
piloted for a three-month period and outcomes included a reduction in incidence of UTI
from 5.4 to 3.8 infections per 1000 resident days and statistically significant
improvements in center compliance with clinical practice guidelines for recognition and
management of suspected UTI. The analysis of cost, benefits, and sustainability of this
evidence-based guideline is discussed.
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I. INTRODUCTION
Infections are a significant source of illness and death in the long-term care (LTC)
setting. Infections account for about 25% of hospital admissions from LTC nursing
centers and the incidence of infectious diseases in nursing centers is on the rise (Vance,
2001). By 2030 the number of older adults in the United States (U.S.) is projected to
reach 71.5 million, representing approximately 20% of the national population (Federal
Interagency Forum on Aging-related Statistics, 2008). The 2004 National Nursing Home
Survey found 1.5 million residents living in 16, 628 nursing homes across the U.S.;
88.3% of them are older adults (U.S. Department of Health and Human Services, 2009).
Although only around 4% of the U.S. population lives in a nursing home at any given
moment, it has been estimated that greater than 40% of the older adult population in our
country will spend some time in a nursing home during their lifetime. The risk of
Healthcare Associated Infections (HAI) in LTC is reported to range from 1.8- 13.5
infections per 1000 resident-care days (Strausbaugh & Joseph, 2000). In light of the
current trend toward shorter hospitalizations, longer nursing home stays, and the growth
of the number of older adults in the U.S. during this century, the likelihood of an
unprecedented increase in the number of LTC residents at increased risk for morbidity
and mortality due to infection is high. Important clinical concerns have arisen from these
trends. The American Medical Directors Association (AMDA) has developed a clinical
practice guideline (CPG) for common infections in the LTC setting. This guideline was
developed by interdisciplinary workgroups using a process combining evidence and
consensus-based thinking, and has been reviewed by national organizations and
individual experts (AMDA, http://www.amda.com/tools/guidelines.cfm). Despite
1

published studies of estimated prevalence rates for infections in LTC and the availability
of clinical guidelines designed for LTC infection control, there are limited data that
evaluate the effectiveness of these measures. There is also a lack of evidence pertaining
to the implementation of such guidelines in LTC. This translates into a heightened need
for attention in healthcare to the unique contributing and modifying factors for infection
in this vulnerable population. This information is particularly pertinent to advanced
practice registered nurses (APRN’s) working in the LTC setting. These APRN’s are
uniquely positioned to potentially impact the integration of evidence-based protocols and
practices into the LTC setting that have the potential to reduce or eliminate HAI’s in this
population.
Clinical Problem
The focus of this project was the incidence of and outcomes associated with HAIs of
the urinary tract in adult residents of a long-term care (LTC) facility. This focus was
driven by a noted increase in UTI ‘s in center residents and unplanned discharges of
residents from the LTC center to acute care facilities with diagnoses of urinary tract
infection (UTI) (Figure 1). These unplanned transfers/discharges were a source of
concern as the result was a loss of revenue for the center. A cohort study by Grenier,
Bell, Bronskill, Schull, Anderson, and Rochon (2010) suggested that UTI is responsible
for almost 25% of the visits made to emergency departments by LTC residents.
Quality indicators were also impacted by these trends in regard to number of
infections and decline in function. Infections are very common in the LTC setting,
represent a major source of morbidity and mortality in LTC, and UTIs are one of the
most common infections in LTC facilities for older adults (Mathei, Niclaes, Suetens,
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Jans, & Buntix, 2007; Smith et al., 2008). Prevalence of urinary tract infections, a quality
indicator, was analyzed for the center. The data was collected from the Mini Data Set
(MDS) system and UTI was defined as it is reported into the MDS system. For the
purposes of reporting, UTI is defined as signs and symptoms of UTI (i.e. dysuria, fever,
urinary frequency, new/increased urinary incontinence) and a urine culture with
microorganisms reported at greater than or equal to 100,000 cfu/ml or a documented
diagnosis of UTI by a medical provider. This analysis confirmed that the rate of
infections was on the rise in the center and was significantly higher than the national and
state percentages (Figure 1). The December 2011 UTI incidence in the center was nearly
twice that of the national percentage. The incidence of UTI in the center had improved
marginally since that time but remained a concern for the facility from a quality
perspective.
Figure 1: Percentage of Urinary Tract Infections in the Center for July-December, 2011
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Purpose and Goals of Project
The overall project goal was to improve the quality of care of LTC residents through
use of best practices for the prevention and management of UTI. The project had several
objectives including: 1) evaluate gaps between current center practices and the AMDA
Clinical Practice Guideline: Common Infections (AMDA CPG: CI) 2) design approaches
to assist the LTC center integrate the evidence into practice, 3) implement the
approaches, 4) evaluate the outcomes (UTI rates, antimicrobial usage and adverse
outcomes), and 5) evaluate the process of systematic implementation of the AMDA CPG:
CI recommendations for reduction and appropriate management of UTI.
In evidence-based practice (EBP), clinical questions are asked in PICOT format.
PICOT is an acronym used to represent Patient population, Issue of interest, Comparison
intervention, Outcome, and Time frame. PICOT format assists the investigators to search
for and retrieve the most relevant and best evidence (Melnyk & Fineout-Overholt, 2011).
This Doctorate of Nursing Practice (DNP) EBP clinical change project PICOT question
was: In patients living in a LTC facility (P), how does implementation of the AMDA
Clinical Guideline: Common Infections (AMDA CPG: CI) (I) compared to current
practices(C) affect urinary tract infection rates, antimicrobial usage, unplanned
discharges (O) over three months (T).
Evidence-based Practice Model
The Iowa Model of Evidence-based Practice to Promote Quality Care is the EBP
model that was used for the project. The Iowa Model is a seven-step process that focuses
on organization and collaboration to incorporate research and other types of evidence into
clinical practice (Titler et al., 2001). The model originated in 1994 and has been
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continually cited in nursing journals and extensively utilized in clinical research
programs (LoBiondo-Wood and Haber, 2006). The Iowa Model employs a linear design
with multiple “feedback loops” that facilitate fluid movement through the evidence-based
process with analysis and evaluation at each step (Titler et al., 2001). A factor that
illustrates the goodness of fit for the Iowa Model to this project is the concept that not
only evidence from the literature, but also internal evidence from the organization is
integrated (Titler et al., 2001). Table 1 displays the seven steps of the Iowa Model as
applied to the project.
Table 1: Application of the IOWA Model to the EBP Project
Steps of the Iowa Model

Proposed Project Application

STEP 1
Selection of a Topic

Trigger of increased unplanned discharges from center to acute care
with diagnoses of infection was noted (UTI was most common).
Director of Nursing and Director of Clinical Services and APRN met
to analyze center quality indicators. A combination of data from the
MDS and chart reviews were utilized. UTI in the facility was noted to
be increasing over past months.
Topic of “Reducing UTI’s in the center and improving outcomes”
was determined
This clinical problem was accepted as having high organizational
priority related to the impact on quality and financial aspects in the
center.

STEP 2
Forming a Team

The interdisciplinary team members will include:
APRN- project leader
Director of Nursing
Assistant Director of Nursing
Medical Director of the center
Pharmacist Consultant
The APRN led this step. The current evidence was searched and
retrieved. Databases searched included: CINAHL, PubMed,
Cochrane Database of Systematic Reviews.
The APRN lead this step.
See Evaluation and Synthesis Tables
The APRN presented the results of the search Strategy and Synthesis
to the team members at the center’s monthly Quality Meeting.
The AMDA guideline was discussed and determined by the group to

STEP 3
Evidence Retrieval
STEP 4
Grading the Evidence
Step 5
Developing an EBP
Standard

5

Step 6
Implementing EBP

Step 7
Evaluation of the
Change

be the most applicable for the center in regard to appropriateness,
feasibility, meaningfulness and effectiveness.
The team developed a plan, timeline and process for implementation
of the standard.
Pilot site for the project was selected.
Review of current policies, procedures in comparison to AMDA
CPG:CI completed.
Baseline UTI rates in the center were identified.
Baseline antibiotic usage in the center was identified.
Retrospective chart reviews were completed on resident records to
analyze the current practices in comparison to the AMDA Guideline.
sUTI Worksheet was developed for integration of the AMDA CPG:
CI.
Education of staff/clinicians completed regarding the
guideline/intervention/processes.
A retrospective chart review of resident records was completed 3
months following full implementation of the intervention to evaluate
compliance with the guideline and determine outcome data.
Incidence of UTI, antibiotic usage, and unplanned discharges were
compared to the baseline.

The Iowa model also emphasizes problem solving and is “widely recognized for its
applicability and ease of use by multi-disciplinary healthcare teams” (Melnyk & FineoutOverholt, 2011, p.251). This was a major consideration in the selection of the Iowa
Model as the project utilized a multi-disciplinary team approach involving nursing,
medicine, administration, and pharmacy.
The EBP Clinical Change Project
The setting for the clinical change project pilot was a 98-bed, for-profit,
Medicare/Medicaid certified extended care nursing center in rural southwest Ohio. The
seven steps of the Iowa Model served as the guiding framework for organizing the project
from planning through evaluation. The Iowa Model employs a linear process design but
emphasizes fluid movement within the process based on evaluation at each step (Titler et
al., 2001).
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Iowa Model Step 1: Selection of a Topic
The first step in the Iowa Model is selection of a topic with emphasis on
identification of a problem- focused trigger. The problem-based trigger for this project
was presented in the introduction with the statement of the clinical problem and PICOT
question. The Iowa Model identifies the importance of ascertaining that the clinical
problem being addressed is an organizational priority in order to facilitate cooperation
and support for the project. The problem identified for this project had clearly been
accepted as an organizational priority as it stood to impact both the financial and quality
aspects of the center. In the LTC setting, the key stakeholders encompass the
organization’s hierarchy including: corporate leaders, center administration, medical
providers, nurse supervisors, all front line and ancillary staff, patients and families.
Iowa Model Step 2: Forming a Team
The second step in the Iowa Model is selection of a team. As part of the project
development, this DNP student, as project leader, met with the center administration and
solicited suggestions for the EBP Project Team membership. Upon consideration of those
recommendations and the need to involve members from multiple disciplines, the EBP
team will be comprised of the following members:
•

APRN- the Doctorate of Nursing Practice (DNP) student was an APRN and
served as team leader for the EBP Practice Change Team. The role of the APRN
was to lead the EBP process and report to stakeholders as necessary to gain
support/resources, educate the team members on the Iowa Model and the EBP
processes, and lead the team through the project implementation and evaluation.
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•

Director of Nursing (DON) - this individual’s support of the clinical project was
essential as the role and responsibility of the DON is for day-to-day operations of
the nursing department and review of policy. DON buy-in to the project was a
critical first step in the implementation process. The DON role on the committee
was to provide guidance on data sources and retrieval, input on policy review and
revision, and leadership for the marketing of the project.

•

Assistant Director of Nursing (ADON) - this individual was involved in both the
planning and implementation phases of the project as the CSD oversees the
infection surveillance activities, the immunization program and facilitates the
clinical education and in -servicing.

•

Medical Director- this individual drove the acceptance of the guideline by center
clinicians, participated in review/revision of current policy, and served as a key
advisor in development of the protocol.

•

Pharmacist Consultant- this individual will provide expertise for the analysis of
antibiotic usage and concerns related to the project.
As part of the project pilot development, an initial meeting of the EBP Project Team

was held and the APRN introduced the problem-based trigger, the PICOT question, and
the preliminary literature review findings. The AMDA CPG: CI was discussed and
determined by the team to be the most applicable for the center in regard to
appropriateness, feasibility, meaningfulness and effectiveness. The resources necessary
for implementation were discussed and determined to be feasible. The team accepted the
PICOT question as proposed and acknowledged the role that each member will fulfill as
part of the team. The team acknowledged that historically, integration of CPG’s in LTC
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has been fragmented and difficult to evaluate. Gaining support and buy-in for this EBP
project from those involved in the performance improvement was essential for success of
the project. Anticipated barriers to implementation of this clinical change project
identified by the EBP Project Team included:
•

Need for staff buy-in and accountability for utilizing the EBP project process.

•

Sustainability of the guideline across shifts and over time.

•

Acceptance of and compliance with guideline recommendations by all facility
medical providers.

•

Lack of history of culture in support of EBP within the center.

•

Historical limited engagement by professional pharmacy and medical
professionals in quality improvement activities in the center.

The anticipated barriers were addressed through frequent communication from the
project team to staff and stakeholders. The center in which the pilot was completed is part
of a large corporation with sizable clinical resources available. Anticipated Facilitators of
the clinical change project identified by the EBP Project Team included:
•

Support from the DON, center Administrator, and nursing leadership with the
clinical problem identified as an organizational priority.

•

Administrator support for compensation of staff/team members for team meeting
times and educational time.

•

Medical Director support of the project.

Appendix A contains the barriers and the specific strategies utilized for addressing these
as well as the facilitators and the strategies employed to sustain them throughout the
project.
9

II. LITERATURE SEARCH, APRAISAL, AND ANALYSIS
In this section, the clinical literature and clinical practice guidelines relevant to UTI
in LTC and integration of CPG’s in LTC are reviewed and analyzed. The seven steps of
the Iowa model continue to be utilized as an organizing framework. The significance of
this analysis to the project are discussed and gaps between the existing literature and
clinical practice are acknowledged.
Iowa Model Step 3: Evidence Retrieval
The literature review is an essential aspect of the Iowa Model. The APRN led the
retrieval of evidence from electronic databases including: The Cumulative Index of
Nursing and Allied Health (CINAHL), PubMed (Medline) and the Cochrane Database of
Systematic Reviews. The AMDA Guideline: Common Infections was also appraised as
were several other national guidelines pertaining to UTI prevention. Grey literature was
avoided in this literature review as adequate research-based articles were identified.
Studies were identified through a search of the aforementioned databases from 2000 to
the present using subject headings “urinary tract infection” or “UTI” combined with
“long term care” or “LTC” with the use of controlled vocabulary through the databases.
Limits were also set in the PubMed database to include only those articles available in
English, dated 2000 or more recent, age 19+ years, clinical trial, meta-analysis, practice
guidelines, and randomized control trials. This strategy reduced the hits from 28,918 to
1,033. Adding an additional limit of evidence-based medicine (EBM) reduced the hits to
16. Limits were set in the CINAHL database to include articles in English and EBP only.
This strategy reduced the hits from 2157 to 62. A search of the CINAHL database for
the keywords “clinical practice guidelines” combined with “long term care” yielded nine
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hits. The PubMed (Medline) databases was also searched with the terms “clinical practice
guidelines” and “urinary tract infections” with limits of human, aged 65+ years, and
English which yielded 47 hits. The Cochrane database was searched with the keyword
“urinary tract infection” combined with “older adults” or “long term care” which yielded
25 hits. The search strategy was repeated September 2013 with additional limits of date
range December 2012- 2013 to update the original literature search and yielded one
additional systematic review of infection prevention in LTC. The final cohort hits were
reviewed by reading the abstracts and only those articles pertaining specifically to urinary
tract infection in long term care or the older adult and prevention or reduction of infection
and having publication dates 2010 or more current will be retained for appraisal from the
Cochrane, CINAHL and PubMed databases. The final number of
articles/studies/guidelines retained for future critical appraisal was 17. The abstracts
contained information suggesting that these articles pertain specifically to urinary tract
infection in long term care and impact on adverse outcomes or rate of infection, or
implementation of CPGs in LTC. All articles pertaining specifically to the use or
evaluation of CPG’s in LTC with publication dates in the past 10 years were included.
No articles were identified that were specific to the PICOT question in regard to
evaluation of use of the AMDA CPG: CI and impact on UTI rates or outcomes. The
search strategy and results are summarized and presented in Appendix B. The evidence
included and excluded with rationale are presented in Appendix C.
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Iowa Model Step 4: Grading and Synthesis of the Evidence
This step in the Iowa Model includes the critical appraisal and synthesis of
evidence. Relevant literature was evaluated and summarized in a table format. Refer to
Appendix C for this summary of the literature. Melnyk & Fineout-Overholt’s (2011)
rating system for the hierarchy of evidence was utilized to grade the evidence. This
system was adapted from Guyatt and Rennie’s hierarchy and includes seven levels of
evidence with level one evidence being considered the highest level of evidence and level
seven being the lowest level of evidence. The evidence was examined and the essential
elements considered beginning with level I evidence and moving down the hierarchy.
There is a paucity of existing studies pertaining to the prevention and management of
UTI specifically in the LTC setting (Uchida, Pogozelska-Maziarz, Smith & Larson,
2013). This lack of scientific evidence to evaluate recommended interventions is a source
of much concern and support for the need for nursing research in this area.
Three CPGs, which were considered level I evidence based on the strategies used in
guideline development, were evaluated. Two of these CPGs were included in the AMDA
CPG: CI. The third CPG (HICPAC Guideline for Prevention of CAUTI-2009) was not
included in the AMDA CPG: CI likely due to it being released after the AMDA guideline
was developed. The HICPAC guideline provides a rich source of descriptive grading of
evidence in support of the included recommendations. As many of these
recommendations are included in the AMDA CPG: CI, this new CPG lends further
support to the AMDA CPG: CI. The AMDA CPG: CI is derived from evidence-based
guidelines, current available evidence and expert consensus. The AMDA CPG: CI was
developed under a project conducted by AMDA-Dedicated to Long Term Care Medicine,
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the national professional association of medical directors, attending physicians, and
others practicing in long term care. The development of the guideline used a process of
combined evidence and consensus –based approaches. The process to guideline
development is described as systematic and including literature review, framework
development, and interdisciplinary contributions. AMDA relates the ongoing issue of
limited scientific evidence in LTC as requiring some recommendations to be based on
expert consensus. Each recommendation within the guideline is linked with the scientific
evidence available. There is, however, a lack of detailed explanation of the quality of
evidence supporting the recommendations. The recommendations are clinically relevant
to the LTC setting, are practical and feasible in the LTC setting, and are in alignment
with current practice. The outcomes of the guideline can be measured through standard
care with analysis of outcomes data from the MDS database, chart reviews, as well as
other existing center data sources. The AMDA Clinical Practice Guideline Steering
Committee reviews the guideline every three years. The results of the critical appraisal
of the AMDA CPG: CI and the three other CPG’s are summarized in Appendix D.
The scientific evidence pertaining to the implementation and evaluation of CPG for
UTI prevention in LTC is quite limited. Much of the literature that relates to this topic
takes the form of expert opinion or applied research of older adults and geriatric
medicine. For the purposes of this literature review, key evidence within the AMDA
CPG: CI pertaining to UTI was identified and is presented in Appendix C. The overall
level of evidence that supports the use of the AMDA CPG: CI is moderate. The AMDA
CPG: CI is an evidence-based and practice- based guideline consistent with level B
strength of recommendations utilizing the USPSTF system for evaluating evidence to
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support recommendations as there is moderate certainty that the benefit of the
intervention is moderate to substantial and benefits outweigh harms
(http://www.ahrq.gov/about/evaluations/uspstf/uspstfeval1.htm). The AMDA CPG: CI
incorporates evidence from the highest level of evidence currently available (CPG’s from
leading healthcare organizations). There are elements of the guideline that have high
quality evidence to support the recommendations but there are also some components that
are not based on high quality evidence due to the lack of such evidence; in these
instances, the guideline developers provide expert consensus data to support the
recommendation. The AMDA CP G: CI provides a synthesis of the available evidence
pertaining to the most common infections encountered in LTC. Table 6 displays the
critical appraisal data for the AMDA CPG: CI, as well as the Infectious Diseases Society
of America (IDSA) CPG for catheter-associated UTI (2010), and the Society for
Healthcare Epidemiology of America (SHEA)/Association for Professional in Infection
Control and Epidemiology (APIC) for infection prevention and control in the long term
care facility which are included in the AMDA CPG: CI. Table 6 also includes critical
appraisal data for the Healthcare Infection Control Practices Advisory Committee
(HICPAC) of the Centers for Disease Control (CDC) guideline for prevention of catheterassociated UTI. These CPG’s represent the highest level of evidence available regarding
UTI in LTC.
The entire AMDA CGP: CI appears to be best implemented utilizing an
interdisciplinary team approach in the center. The guideline takes a general approach to
infection control but also includes specific recommendations for the most common
infections encountered in the LTC setting including UTI. The synthesis of the current
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evidence into this comprehensive guideline, which contains strategies and considers
factors that are unique to the LTC setting, was a necessary first step toward facilitating
higher quality evidence to support these recommendations in the LTC setting.
The literature regarding CPG use in LTC is also sparse and limited to small
retrospective studies and several qualitative studies. Seven studies pertaining specifically
to CPG use in LTC were identified and appraised (Appendix E). Deuster et al. (2010)
conducted an intervention study to evaluate the use of treatment guidelines to improve
antibiotic therapy use (N=100) and found that implementation of treatment guidelines
increased the appropriate antibiotic use in a LTC facility. A systematic review by
Flodgren et al. (2013) examined the efficacy of strategies to promote staff adherence to
infection control measures and in thirteen studies found insufficient evidence to support
any specific measures changing adherence behaviors. A qualitative study by Resnick et
al. (2004) explored the feasibility of implementing CPG’s in LTC settings and resulted in
four themes being identified: 1) challenges to implementation, 2) benefits of
implementation, 3) process recommendations, and 4) recommendations for changes to
CPGs. Another qualitative analysis by Colon-Emeric (2007) identified additional barriers
to implementation of CPGs in LTC. In a retrospective study, Wipke-Tevis et al. (2004)
(N=362) revealed that forty percent of LTC facilities were using a tool to assess pressure
ulcer risk and prevention that was not evidence-based. Hutt et al. (2006) conducted a
quasi-experimental pre-post test with a control group to assess feasibility of the use of
evidence-based guidelines for treatment of community-acquired pneumonia in nursing
homes; findings suggested that compliance with some guideline components improved.
Berlowitz et al. (2001) conducted a survey to determine whether and how CPGs were
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being used in nursing homes (N=1065) and found that less than fifty present reported
adoption and use of CPGs.
Analysis of the literature indicates that although CPG’s applicable to LTC are
available, the actual systematic implementation of CPG’s in this setting remains poor
(Berlowitz, et al., 2001; Colon-Emeric, et al., 2007; Resnick, Quinn, & Baxter, 2004).
Several studies have indicated that the potential for CPG’s to improve quality and
compliance with current practice standards is good (Deuster, Roten, & Muehlebach,
2010; Hutt, et al., 2006). Results of qualitative studies have supported the feasibility of
the use of CPG’s in LTC as a means of quality improvement in regard to improvement in
documentation and outcomes (Colon-Emeric et al., 2007; Resnick et al., 2004).
Qualitative data also provided some perceptions regarding barriers to the implementation
of CPG’s including perceived lack of congruence between the guidelines and the
patient/family wishes, lack of congruence of guidelines with current policies, perception
of guidelines as inhibiting individualized care, getting staff buy in, dealing with issues of
staff turnover and sustaining implementation as new staff replace old, and ensuring
accountability of nursing staff to promote the use of the guidelines(Resnick et al.,2004;
Colon-Emeric et al., 2007). The same studies also identified some potential facilitators of
implementation of CPG’s in the LTC setting which included streamlining the guidelines
into algorithms, incorporating the guideline recommendations into standing orders,
implementing one CPG at a time, designating a person or small team to champion the
implementation of the guideline, developing tools for each guideline, and involving staff
in a stepwise education process for implementation (Colon-Emeric et al., 2007; Resnick
et al., 2004). The Institute of Medicine (IOM) recommends the use of CPG’s, which
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synthesize the most current and quality evidence and expert opinion into best practice
standards (Institute of Medicine, 2000). A single systematic review assessed the efficacy
of interventions which target healthcare professionals or organizations to improve
professional adherence to infection control guidelines on device-related infection rates
and suggested that educational interventions with multiple active elements that are
administered repeatedly over time are most effective (Flodgren et al., 2013). An
intervention study measuring effectiveness of incorporating a practice algorithm for
suspected UTI in LTC patients resulted in a UTI rate reduction by 30% and antibiotic
usage reduction of 20%, which persisted over twelve months (Genao & Buhr, 2012).
Similarly, another intervention study utilizing an educational intervention noted sustained
reductions in inappropriate treatment of asymptomatic bacteriuria in a LTC center
(Zabarsky, Sethi, & Donskey, 2008). An increasing number of CPG’s have been
developed specifically for use in LTC. The AMDA has led the way of this trend with
evidence-based CPG’s that take into account many of the factors unique to the LTC
environment. The existing literature provides some important considerations in quality
improvement intervention development. The pertinent literature from 2010 (the last
publication date included in the AMDA CPG: CI) to the present was evaluated and is
presented in Appendix F. Further discussion of the literature is included in Step 5 with
the recommendations for practice change.
Iowa Model Step 5: Developing an EBP Standard
Recommendations for Practice Change
This step of the Iowa Model involves establishing recommendations for practice
change based on the evidence. The evidence clearly supports that infections are a
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significant source of morbidity and mortality in the LTC setting (Tsan, et al., 2010). The
AMDA, the premier professional association for LTC clinicians, has developed a clinical
guideline for the four most common infections in the LTC setting (respiratory, urinary,
gastrointestinal, and skin/skin structure). This guideline was developed by
interdisciplinary workgroups using a process combining evidence and consensus-based
thinking, and has been reviewed by national organizations and individual experts
(AMDA, http://www.amda.com/tools/guidelines.cfm). The practice recommendation was
the systematic implementation of the AMDA CPG: CI to address the PICOT question.
This CPG represents the highest available evidence for prevention and management of
UTI in the LTC setting as it is a CPG based on systematic review of available evidence
(AMDA, 2011). The clinical change project intervention was an evidence-based and
practice- based guideline consistent with Level B utilizing the USPSTF system for
evaluating evidence to support recommendations as there is moderate certainty that the
benefit of the intervention is moderate to substantial (U.S. Department of Health and
Human Services, 2012). There is a noted lack of evidence in the literature that evaluates
the use of CPGs in LTC in regard to impact on outcomes. The project integrated the
most current practice standards and best practices for infection prevention, recognition,
and management in efforts to add to the much-needed evaluation of the CPG in this
setting.
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III. IMPLEMENTATION
In this section the project implementation is described. The specific practice
recommendations with rationale from the body of evidence are presented within the
framework of the twelve steps of the AMDA CPG: CI and are summarized in Table 2.
Specific elements relative to the project interventions are also discussed here.
Table 2: Summary of Recommendation for Practice Change
PICOT Question
In patients living in a LTC facility (P), how does
implementation of the AMDA Clinical Guideline: Common
Infections (AMDA CPG: CI) (I) compared to current
practices(C) affect urinary tract infection rates, antimicrobial
usage and adverse outcomes (O) over three months (T).
Practice Change
Recommendation

Level of
Effectiveness

References in
Support of
Recommendation

Systematic implementation of the AMDA Clinical Guideline:
Common Infections including:
1. Establish protocol for initial nursing assessment/evaluation
of suspected UTI
2. Establish protocol for appropriate laboratory test
evaluation of suspected UTI
3. Establish protocol for evaluation of need for transfer to
acute care facility
4. Establish protocol for implementation of appropriate
transmission precautions
5. Establish process for ongoing monitoring and
documentation of patient response to treatment for
infection.
6. Implement an immunization program for all center patients
7. Implement a center-wide infection control program that
conforms to federal and state regulations and current
standards of practice.
8. Monitor management of infections in the center.
9. Monitor antibiotic use in the center.
The project intervention is an evidence-based and practice- based
guideline consistent with level B utilizing the USPSTF system for
evaluating evidence to support recommendations as there is
moderate certainty that the benefit of the intervention is moderate
to substantial
(http://www.ahrq.gov/about/evaluations/uspstf/uspstfeval1.htm)
This CPG represents the highest available evidence for prevention
and management of UTI in the LTC setting as it is a CPG based on
systematic review of available evidence and expert consensus in
the field (AMDA, 2011).
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AMDA CPG: CI Step 1: Recognition
In this step the guideline emphasizes the importance of prompt recognition of signs
and symptoms consistent with infection. This step includes evaluation of vital signs,
mental status compared to baseline, and the importance of nursing staff reporting these
acute changes of conditions to healthcare providers. The evidence supports that
infections, including UTI’s, in LTC residents predispose to serious consequences such as
dehydration, delirium, falls, sepsis, hospitalization, and even death (Engelhart, HansesDerendorf, Exner, & Kramer, 2005; Mylotte, 2005). In the LTC population UTI’s
account for approximately one fourth of all infections (Foxman, 2002; Ruben et al.,
1995). UTI’s have also been estimated to account for up to sixty percent of systemic
antimicrobials used in the LTC setting (Nicolle, 2001; Nicolle, 2003). UTI’s that are not
recognized and managed appropriately may also lead to the need for hospitalization of
LTC residents that can cause disruptions in care, “discomfort and anxiety for residents
and families, iatrogenic complications during hospitalization with related morbidity, and
excess health care costs” (Ouslander et al., 2009, p. 645). The project team developed a
suspected UTI (sUTI) worksheet to be utilized by center nursing staff when a patient is
suspected of having a UTI (Appendix J). The sUTI worksheet was developed from the
AMDA CPG: CI and included criteria for change in patient condition that suggests UTI.
Staff used these criteria to determine when further assessment for sUTI was warranted.
AMDA CPG: CI Step 2- 4: Assessment
In these steps the guideline emphasizes the performance of a targeted history and
physical exam that aligns with the likely sources of infection based on presenting
symptomology. This step includes diagnostic testing as appropriate. In regard to UTI,
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the guideline suggests the use of clinical signs and symptoms to guide the judicious use
of urinalysis and culture. This is further supported by the 2009 study by Juthani-Mehta et
al. in which clinical features associated with bacteriuria plus pyuria (the proposed clinical
definition for UTI) were found to be dysuria, change in character of urine, and change in
mental status. This study further supports the recommendation of the AMDA CPG: CI
for assessment and reporting of clinical features suggestive of UTI promptly to providers
so that a clinical decision can be made. The guideline suggests that positive urine
dipstick or presence of leukocyte esterase on urinalysis suggest that a urine culture should
be performed. Furthermore, the guideline recommends avoiding follow up urine culture
after antibiotic treatment due to the high incidence of asymptomatic bacteriuria in the
LTC population. Asymptomatic bacteriuria is prevalent in the LTC population and
several randomized clinical trials among LTC residents have demonstrated that treatment
of AB is not beneficial (Abrutyn et al., 1994; Nicolle, Mayhew, & Bryan, 1987; Nicolle,
Bjornson, & Harding 2000). Despite the recommendations that treatment of AB with
antimicrobials be avoided in LTC, the practice remains common in this setting (Loeb et
al., 2001). An intervention study in an Ohio LTC facility involving an educational
intervention demonstrated sustained reduction in inappropriate treatment of
asymptomatic bacteriuria as well as decreased overall antimicrobial use (Zabarsky, et al.,
2008). Genao and Buhr (2012) reported a thirty percent decrease in suspected UTI and
twenty percent decrease in antibiotic usage over a three-month period with the use of a
nursing-driven algorithm for suspected UTI management.
Inappropriate treatment of AB with antimicrobials results in adverse drug events,
emergence of MDRO’s, occurrence of c. difficile diarrhea, and increased costs (Aubrutyn
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et al., 1994; Nicolle, 2001, Nicolle, 2003; Ouslander et al., 2009). Infections with
MDRO’s have long-reaching consequences for the health of LTC residents and the
general public. Morbidity associated with infection with MDRO’s leads to increased
costs associated with increased hospitalizations, treatment, and implementation of
infection control measures (Straussbaugh, Crossley, Nurse, & Thrupp, 1996). MDRO
infections may also contribute to a lower health-related quality of life and functional
decline (Loeb et al., 2001).
Assessment also includes determining whether a patient’s condition requires
transfer to an emergency department or hospital setting when the patient has unstable
vital signs, diagnostic tests are not available in the center, or the scope of monitoring or
treatment exceeds the capabilities of the center. The assessment component also
addresses the need for assessment of LTC patients for appropriate use of indwelling
urinary devices. The AMDA CPG: CI incorporates recommendations from the IDSA
CPG for catheter-associated UTI (2010), and the SHEA/APIC guideline for infection
prevention and control in the long term care facility. The new HICPAC of the CDC
guideline for prevention of catheter-associated UTI provides additional support for these
recommendations for evaluation of appropriate short and long-term catheter use, catheter
management strategies, and diagnostic criteria for UTI in the LTC setting. An
intervention study reported that the use of a nursing-driven algorithm for determining
appropriateness of indwelling urinary catheter placement reduced total catheter days by
twenty percent (Magers, 2013). The HICPAC CPG sets a new standard for
documentation of grade of evidence to support recommendations with comprehensive
evidence tables and recommendations for further research. Finally, assessment requires
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the determination of the need for heightened infection control precautions. Specific to
UTI this may include the containment of urine that is potentially contaminated by multidrug resistant organisms (MDROs). Standard precautions are those applied at all times to
all patients and transmission precautions are those that should be implemented in the case
of known or suspected transmissible diseases.
The sUTI worksheet delineated the pertinent history and physical exam elements
from the AMDA CPG: CI . These elements included vital signs, mental status, and
urinary symptoms. The worksheet also provided the criteria for laboratory urinalysis and
culture and implementation of appropriate transmission precautions.
AMDA CPG: CI Step 5 and 6: Treatment
These steps of the guideline focus on the targeted treatment of the symptoms of
infection through use of supportive measures for comfort (i.e. treatment of fever,
maintenance of fluid intake, monitor nutritional status and initiate nutritional
interventions as needed). The treatment component of the guideline also addresses
antibiotic therapy. The guideline suggests that empiric therapy based on center
epidemiologic data and the most likely source of infection may be warranted but stresses
the importance of specific therapy through culture when possible. The guideline refers to
current CPGs for CAUTI in regard to limiting duration of antibiotic therapy for UTI.
Deuster et al. (2009) further support the AMDA CPG: CI recommendation for referral to
targeted antibiotic treatment guidelines to support the judicious use of antibiotics in LTC.
The sUTI worksheet prompted staff to determine whether the patient met AMDA CPG:
CI criteria for empiric treatment with an antibiotic and to communicate this to the
provider when reporting the change in condition.
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AMDA CPG: CI Step 7-12: Monitoring
The monitoring component of the guideline refers to monitoring of: 1) Patient
response to treatment, 2) monitoring for, identifying and containing identified outbreaks
of infection, 3) implementing and monitoring an immunization program for patients, 4)
implementation of a facility-wide program of infection prevention and control that
complies with both state and federal LTC regulations as well as current practice
standards, 5) monitoring of infection management in the center, and 6) implementing an
antibiotic stewardship program in the center. Specific to UTI these guidelines can be
interpreted to include the need for monitoring of response to antibiotic therapy including
assessing for recurrent infections and appropriate referral for urologic evaluation when
warranted. It suggests that a comprehensive program of infection prevention and control
including staff education of aseptic catheterization and urine specimen collection
techniques be implemented. Perhaps most importantly, the guideline suggests a program
of monitoring infection trends in the center and participating in antibiotic stewardship
through evaluation of appropriate antibiotic prescribing and appropriate follow up with
providers.
Iowa Model Step 6: Implementing EBP
The project was submitted for expedited review through the Wright State University
Institutional Review Board. The project was determined to be exempt from Institutional
Review Board approval. Project implementation included three phases. Each phase is
presented in the following sections. Appendix H contains an outline for the project
including final implementation and evaluation timeline.
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Implementation phase I.
The EBP Project Team determined the specific project implementation timeline and
communicated this to key stakeholders via a brief presentation. The EBP Project Team
reviewed current policies and procedures in comparison to AMDA CPG: CI for infection
control measures, immunization program, and infection and antimicrobial surveillance. It
was determined that current policies and procedures regarding immunization and
infection control were in compliance with the AMDA CPG: CI. It was also determined
that the antibiotic surveillance elements of the guideline were also being partially
followed. The pharmacy and laboratory provided the appropriate antibiotic usage and
aggregate microbe reports but these were not being shared routinely with providers. The
ADON added the monthly antibiotic and microbe reports to the agenda for the routine
Quality Committee meetings to close this gap. Baseline data for the outcome indicators
were assessed and recorded by the EBP Project Team through retrospective chart audits
(Appendix I). The MDS and resident chart reviews were the sources of data at both preintervention and post-intervention. Charts were reviewed for treatment of asymptomatic
bacteriuria and appropriate implementation of transmission precautions in residents
identified as having been treated for UTI in the center. Retrospective chart reviews were
completed on records of residents identified as having been treated for UTI in the three
months pre-intervention to analyze the center practices in comparison to the AMDA CPG:
CI.
Implementation phase II.
The EBP Project Team analyzed results of this assessment and determined that an
evidence-based, nursing-driven protocol for suspected UTI was appropriate to facilitate
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improved integration of the CPG. The EBP Project Team developed the sUTI protocol
worksheet (Appendix J) and staff/provider education related to the protocol based on the
systematic evaluation of gaps between current center practices and comparison to the
AMDA CPG: CI. A PowerPoint presentation (Appendix K) was utilized for
staff/provider education in addition to return demonstration of technique for dipstick
urine collection and performance, and role-playing of communication of protocol
elements between staff and providers.
Implementation phase III.
The Project Leader in collaboration with the nursing leadership completed formal
staff/provider education for the intervention including instructions for use of the sUTI
worksheet. The EBP Project protocol was piloted for a period of three months. The
sUTI Protocol binders with worksheets were placed in convenient locations in the nursing
documentation area. The Project Leader made site visits to the center monthly during the
pilot period and talked with individual and small groups of nursing staff regarding
protocol utilization. Project Team members were present at monthly nursing staff
meeting in the center and provided reminders for all staff regarding protocol utilization.
Iowa Model Step 7: Evaluation of the Clinical Change
Selection of Outcomes and Methods.
Identification of outcome indicators is a critical step in a practice-based project. The
outcome indicators for this project were derived from the overall project goal and
purpose. Donabedian’s S-P-O Model was utilized as a framework for the evaluation
components of the project. Donabedian (2005)) suggested that quality may be evaluated
using three approaches either as a stand-alone approach or in combination with the other
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approaches: 1) structure of care, 2) process of care, or 3) outcome of care. For this
project, assessment of the status of current structure indicators was completed as part of
the project planning through assessment of administrative support and analysis of
potential barriers and facilitators. The process and outcome approaches to evaluation
utilized for the evaluation of this project are summarized and presented in Appendix G.
The outcome indicators included: 1) incidence of UTI per 1000 resident days and 2)
incidence of unplanned discharges from the center to acute care facilities/emergency
room for UTI/urosepsis per 1000 resident days, and 3) antibiotic usage. The Minimum
Data Set (MDS) and patient charts were the sources of data for these outcome indicators.
The process indicators of AMDA CPG: CI implementation were also evaluated and
included: 1) evidence of process for suspected UTI risk, 2) evidence of suspected UTI
assessment according to the AMDA CPG: CI, 3) evidence of appropriate diagnostics for
suspected UTI according to the AMDA CPG: CI, 4) evidence that residents with
suspected UTI being treated with antimicrobials therapy met criteria for UTI, 5) evidence
that appropriate transmissions precautions were implemented for UTI caused by multiple
drug resistant organisms (MDRO’s), and 6) staff evaluation of process. Staff evaluation
of the process was evaluated through use of focus groups to identify staff perceptions of
what went well, what could have been improved, and strategies for future improvements
in regard to the project process. Chart audits were the primary source of data for the
remaining process indicators.
Measurement and evaluation of the quality of health is a complex process. The
evidence supports that infections, including UTI’s, in LTC residents predispose to serious
consequences such as dehydration, delirium, falls, sepsis, hospitalization, and even death
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(Engelhart, et al. 2005; Mylotte, 2005). These factors made the outcome and process
indicators of the project pertinent to the attainment of the project overall goal of
improving quality of care for residents of a LTC center through best practices in UTI
prevention and management and were critical indicators of project success.
The outcome indicators of incidence of UTI per 1000 resident days, number of
unplanned discharges to acute care/ER for UTI/urosepsis, and antibiotic usage were
collected from the MDS and resident charts at both pre-intervention for baseline data and
post-intervention for evaluation data. The process indicators of: 1) evidence of process of
suspected UTI risk, 2) evidence of suspected UTI assessment in compliance with the
AMDA CPG: CI, 3) evidence of appropriate diagnostics for suspected UTI in compliance
with the AMDA CPG: CI, 4) evidence that residents with suspected UTI being treated
with antimicrobial therapy meet criteria for UTI, and 5) evidence that appropriate
transmission precautions are implemented for UTI caused by MDRO’s were evaluated
through the post-intervention chart audit with the audit tool based on the AMDA CPG:
CI(Appendix I). Appendix G outlines the evaluation components and measures utilized in
the project.
Cost Considerations
Infections are a significant source of morbidity and mortality in the LTC setting
(Tsan et al., 2010). The infection rates for patients in LTC ranges from 1.8-13.5
infections per 1,000 resident-care days (Smith et al., 2008). Infections are the reason for
nearly half of all unplanned discharges from LTC facilities to acute care and result in an
estimated financial burden to the nation’s healthcare system of as much as $2 billion
annually (Strausbaugh & Joseph, 2000). Additionally, estimates of the cost of antibiotic
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therapy for infection in LTC are as high as $137 million annually (Smith et al., 2008) and
account for up to 60% of systemic antimicrobials prescribed in the LTC setting (Nicolle,
2001). This has significant implications for the potential for widespread antimicrobial
use and the contribution to antimicrobial resistance (Van Buul et al., 2012).
The cost considerations specific to this project included the material expenses
associated with development time and production of written education materials and
tools, which are presented in Table 3. There were no capital expenses incurred. There
was no cost to the participants. The project team activities were implemented as part of
the existing Quality Committee activities within the center. Therefore, additional
compensation outside of that routinely expected from team members, as Quality
Committee members were not required. The center administration supported project team
activities by allotting time from regular scheduled work hours to be utilized for the
project team activities by salaried employees who were project team members.
Table 3: Project-related Costs
Project-related Costs
Material Expenses
• Paper and ink for fliers and project introduction materials for
stakeholders, and chart audit tools(4 reams @ $6.79/ream and
2 ink cartridges @ $25.09each)
• Paper for educational handouts, sign in sheets, and other printed
materials
(10 reams @ 6.79/ream)
• Additional office supplies for folders, pens, markersapproximated costs
Labor Expenses
All project team member compensation to be covered by facility within
the Quality Committee responsibilities.
Total
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$$Amount
$77.34

$67.90

$ 50.00

$0.00
$195.24

Summary of Implementation Methods
In this section, the strategy for implementing the AMDA CPG:CI in the pilot center
was described. The strategy involved systematic evaluation of center practices compared
to the AMDA CPG: CI to determine gaps in practice, plan interventions to address those
gaps, and finally to implement those interventions. This process led to the development
of a nursing-driven protocol worksheet designed to facilitate integration of critical AMDA
CPG: CI elements into center practices. The implementation process included
interdisciplinary contributions, support, collaboration, and communication. The pan for
data analysis of clinical outcomes as well as process outcomes was also described.
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IV. OUTCOMES
In this section, the outcomes of the clinical change project will be presented. A
description of the data collection, preparation, and entry processes utilized for evaluation
of the clinical and process outcomes is included.
Population
The population for this project consisted of all patients of a 98-bed dually
Medicare/Medicaid certified, for-profit long-term care enter. Two primary care
physicians and a physician assistant provide attending medical management of center
patients. The majority of facility patients have Medicaid as a payor source although
Medicare, private pay, and commercial insurance are also accepted. The facility has a
frail, elderly population with a majority of long-stay (>30 days) patients. A representative
sample of the patents in the center is provided (Table 4). The project sample was a
convenience sample of patients in the center over the six-month project pilot period.
Patient charts were included in the project review for process indicators if during the
review period they were: 1) diagnosed with a UTI, 2) had an antibiotic prescribed for a
UTI, or 3) had urinalysis/culture performed. The total number of patient charts reviewed
at baseline was 49 and post- intervention was 31.
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Table 4: Characteristics of a Representative Sample at the Nursing Center
N= 89
76
77%
23%

Number of Patients
Average age (years)
Females
Males
Payor Source
Medicare
Medicaid
Commercial
Self/private pay

10%
55%
19%
17%

Reliability
The forms used for this project were developed by the DNP student who was also
the Project Leader, based on current and relevant research and with the approval of the
Medical Director of the center who is an expert in long-term care medicine. The Project
Leader provided all education for this project and collected and recorded all data. This
added to the consistency with which the education occurred and with which the process
and outcomes were evaluated both of which enhanced reliability.
Project Measures and Results
Data collected is presented in the sUTI project measures and outcome indicators
tables (Table 5 and Table 6). The data collected reflects both clinical outcome indicators
and process indicators. For the outcome indicators, incidence rates per 1000 resident days
were calculated and for the process indicator, percentages were calculated. Incidence
rates per 1000 resident days were calculated using this formula: number of infections per
month/average monthly resident care days x 1000. The average monthly resident care
days were calculated as the sum of daily census in that month.
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Table 5: sUTI Project Measures and Outcome Indicators
Outcome Indicator
Incidence of UTI per
1000 resident days
Incidence of unplanned
discharges from the
center to acute care
facilities/ER for
UTI/urosepsis per 1000
resident days
Incidence of antibiotic
usage in Center per
1000 resident days

Pre-Intervention
Measurement
5.4

Intervention
Measurement
3.5

Difference
(pre-post)
-2.0

0.3

0

-0.3

13.9

10.7

-3.2

A chi-square test was used to test the rate difference between the pre-intervention and
intervention incidence of UTI per 1000 resident days. The pre-intervention period
incidence rate of UTI was 5.4, whereas incidence rate in the intervention period was 3.5.
The rate difference was 2.0 and it was not significant (χ2(1) = 1.28, p = 0.258). A chisquare test was also used to test the difference in the incidence rate of patients prescribed
antibiotics in the center during the pre-intervention and intervention periods. In the preintervention the incidence rate of antibiotic usage per 1000 resident days was 13.9,
whereas the incidence rate was 10.7 during the intervention period. There was a nonsignificant decrease of 3.2 (χ2(1) = 1.23, p = 0.268). To test the incidence rate difference
between pre-intervention and intervention periods number of unplanned discharges, a
Fisher’s exact test was used because the number of unplanned discharges in both preintervention and intervention periods was <10. The incidence rate of unplanned
discharges for the pre-intervention period were 0.3 and for the intervention period were 0,
the rate difference of -0.3 was not statistically significant (p = 1.000).
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Table 6: Project Measures and Process Indicators
Process Indicator

Evidence of process
for sUTI risk
sUTI assessment
present
Diagnostics for sUTI
in compliance with
CPG
Patients with sUTI
being treated with
antimicrobial therapy
meet criteria for UTI
Appropriate
transmission
precautions are
implemented

Pre-intervention
Measurement
n= 49
24.49%

Intervention
Measurement
n= 31
61.29%

Difference (pre-post)

22.45%

51.61%

29.16%

14.29%

54.84%

40.55%

22.45%

61.29%

38.84%

100%

100%

36.80%

Chi-square and Fisher’s exact tests (depending on the sample size) were used to test
the proportion difference between the pre-intervention and intervention periods
occurrence of specific process indicators in patient records. A chi-square test was used to
compare the proportion of the process indicator of the evidence of process for sUTI risk
between the pre-intervention and intervention periods. During the pre-intervention
period, the measure for this indicator was 24.49% which increased to 61.29% during the
intervention period, there was a significant 36.80% increase (χ2(1) = 10.83, p= 0.001). A
chi square was also utilized to test the proportion difference between the pre-intervention
and intervention periods of the process indicator of sUTI assessment. The process
indicator of sUTI assessment documented for pre-intervention period was 22.45%, this
number increased to 51.61% in the intervention period. The increase of 29.16% was
significant (χ2(1) = 7.22, p=0.007). For the process indicator of diagnostics for sUTI in
compliance with the CPG, pre-intervention measure, a Fisher’s exact test was utilized
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since the number of patients with this indicator was <10 in the pre-intervention period.
The measure of this indicator during the pre-intervention period was 14.29% while the
intervention period measure was 54.84%. The 40.55% increase was significant (p <
0.001). For the process indicator for those patients being treated with antimicrobial
therapy meeting the CPG criteria for UTI, the pre-intervention measure was 22.45%
whereas, the intervention period measure was 61.29%, a chi-square test was utilized to
test the difference and resulted in a significant 38.84% increase (χ2(1) = 12.22, p <
0.001). The final process indicator of appropriate transmission precautions being utilized
for UTI caused by MDRO’s was not subjected to statistical analysis as both preintervention and intervention period measures were 100%.
In addition to the process indicator measures, the process of the implementation of
the project was evaluated through the use of focus groups. Three focus group sessions
were held during the project (once monthly during the intervention period). These focus
groups involved nursing staff, were informal and consisted of three questions:
1. What is going well with the project?
2. What are the challenges of the project?
3. What changes do you think should be made to the project?
Each focus group session lasted approximately 15 minutes. Results from these focus
groups included that overall, staff felt the project was going well, that the project goals
were important to quality of care, and that the protocol was easy to understand and
implement. The perceived challenges of the project related mainly to the time required to
document. Suggestions for improvements included project tools that were displayed more
prominently in the nursing areas and incorporation of protocol elements into the
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Medicare charting flowsheet. Table 7 displays the full results of the outcome measures
and statistical tests for the project including differences and confidence intervals for each
outcome.
Table 7: Project Measures and Statistical Test/Results
Outcome
Indicator

Preintervention

Intervention

Incidence of
UTI per 1000
resident days

5.4

# of unplanned
discharges

Post – Pre

Chi-Square Test

Lower CI

3.5

-2.0

-5.4

1.4

0.3

0.0

-0.3

-1.0

0.3

13.9

10.7

-3.2

-8.8

2.5

1.23

0.268

Evidence of
process for
sUTI risk

24.49%

61.29%

36.80%

15.85%

57.75%

10.83

0.001

sUTI
assessment
present

22.45%

51.61%

29.16%

8.05%

50.28%

7.22

0.007

Diagnostics
for sUTI in
compliance
with CPG

14.29%

54.84%

40.55%

20.48%

60.63%

Patients with
sUTI being
treated with
antimicrobial
therapy meet
criteria for
UTI

22.45%

61.29%

38.84%

18.09%

59.59%

Appropriate
transmission
precautions
are
implemented

100%

100%

# of patients
prescribed an
antibiotic

*= Fisher’s Exact Test used to compute proportional difference
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Upper
CI

χ2(1)

Difference

1.28

p-value
0.258

*1.00

*< 0.001

12.22

< 0.001

Clinical Significance
The results for the project process indicators support the use of education and the
sUTI protocol as an effective intervention to improve compliance with CPG
recommendation related to to sUTI recognition and management in the LTC setting.
There was statistically significance improvement in each of the process indicators
supporting that there was a relevant clinical change that occurred as a result of the
project.
For the outcome indicators of the project, the results were not statistically
significant, but there is clinical significance in the reduction of the incidence of UTI per
1000 resident days from 5.4% which was above the national benchmark of 5.3%
(identified from the national MDS system) during the pre-intervention period to 3.5%
which was below the national benchmark of 5.2% for the post-intervention period. This
outcome is not only a project indicator but also a critical quality indicator for the center.
Despite the lack of statistical significance of the reduction in incidence of UTI, the
clinical implications from a quality of care perspective are significant. Figure 2 displays
the comparison of the baseline (pre-intervention) incidence of UTI to the 3-month
intervention period of incidence of UTI and the corresponding national benchmarks.
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Figure 2: Comparison of UTI Incidence per 1000 Resident Days to National Benchmarks
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There are clinically significant implications related to cost savings that can be
extrapolated from the project outcomes. There was the marked decrease in unplanned
discharges related to UTI/urosepsis to zero. Although the statistical analysis did not show
significance in this measure, the clinical significance is great when considering the
potential impact on quality of life, morbidity and associated costs related to
UTI/urospesis on the LTC patient population. The cost benefits of the project include a
reduction in lost revenue from bed hold days required when Medicaid recipients
experience an unplanned discharge to an acute care facility; the LTC center is reimbursed
only a fraction of the daily rate when a patient is on a bed hold day. For example, a
Medicaid patient for whom Medicaid is reimbursing the facility $164.80/day at the
regular daily rate who is admitted to the hospital will have the room reimbursed at only
$26.98/day. The facility is required to bed hold these rooms for up to thirty days per year
per patient. Additional cost savings can be inferred from reduced laboratory costs for
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urinalyses and cultures completed on those who do not meet criteria for UTI and
subsequent costs associated with antimicrobial treatment for asymptomatic bacteriuria.
There is also the potential for prevention/reduction of MDRO’s and Clostridium difficile
gastroenteritis, which is associated with overuse of antimicrobials (Dellit, Owens, &
McGowan, 2007).
Consider the following case scenario:
Anne Marie is a 74 year old white female residing in a long-term care facility. She
has a medical history significant for moderate Alzheimer’s Dementia, hypertension,
and diabetes mellitus type 2. Today, staff in the center has noted that Anne Marie is
more irritable than usual and seems more confused. She denies any dysuria, or other
urinary symptoms. She is afebrile and her vital signs are within normal parameters for
her. The nurse believes that Anne Marie’s symptoms could indicate a UTI. She
obtains a mid-stream urine specimen and sends it to the laboratory for analysis. The
initial urinalysis is leukocyte esterase negative but shows a few bacteria. The
specimen has been sent for culture. Three days later the culture results come back
with >10,000 cfu’s of E.Coli. In the meantime, Anne Marie was much better the day
following the collection of her urinalysis and the nurse was notified by the oncoming
evening shift that Anne Marie’s family had taken her to a family birthday party the
evening before and that could have explained her behavior change. Her attending
physician is notified of the culture results and she is prescribed a seven-day course of
levofloxacin 500 mg by mouth daily. Subsequently she develops diarrhea requiring
her to wear adult incontinence pads to prevent soiling her clothing, which is
embarrassing to her, and she does not participate in meals in the dining area or center
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activities for four days. She also develops incontinence dermatitis and requires one
week of treatment with a zinc oxide cream to resolve.
This case illustrates a common occurrence in the LTC setting. A patient has a
urinalysis obtained for non-specific symptoms and the subsequent culture reflects
incidental asymptomatic bacteriuria. Although the patient is not symptomatic for a
UTI, treatment is instituted based on culture results. The estimated costs for this
uncomplicated UTI are presented in Table 4. In addition to the obvious monetary
costs, the cost to the patient’s dignity related to the need for incontinence supplies and
the discomfort associated with the diarrhea and related symptoms stand to
significantly impact the patient’s quality of life.
Table 8: Suspected UTI and Associated Costs
Suspected UTI-related service/product
Routine urinalysis with culture
Levofloxacin 500 mg 7 day regimen
Incontinence supplies (6 days)
Additional staff time required for care of
Incontinence and associated symptoms @
Additional .75 hr/8 hour shift x 3 shifts/day x 6 days x
$9.60/hr
Zinc oxide cream x 1 tube

$$ Cost
$98.00
$18.42
$80.00
$129.60

$5.50
Total= $331.52
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V. IMPLICATIONS AND RECCOMMENDATIONS
This evidence-based clinical change project addressed the clinical problem trigger of
increased rates of urinary tract infections in a rural southwestern Ohio nursing center. The
clinical change involved the systematic implementation of the American Medical
Director’s Association (AMDA) Clinical practice Guideline for Common Infections into
the center. An interdisciplinary team approach to evidence-based clinical change was
utilized through use of the IOWA model of evidence-based practice. The significant
implications for this project include support for the use of a nursing-driven, evidencebased protocol to facilitate systematic implementation of CPG’s in the LTC setting and
evidence to support the efficacy of the AMDA CPG: CI guideline for reduction of UTI
rates and antimicrobial usage in the LTC setting.
Strengths and Limitations
The strengths of this project included the involvement of the stakeholders
(providers, nurses, administration, and nursing leadership) who were able to provide
input, knowledge, and support for the project. This project represented the first evidencebased team project in the center and process evaluation indicated that this approach is
well received by staff which paves the way for future projects in the center. This project
is one of very few available examples of systematic evaluation and integration of a CPG
in the LTC setting.
Limitations of the project included the convenience sample, the relatively short
project time period of three months and the resulting lack of ability to establish statistical
significance for project outcomes. Another limitation inherent to the process of this
project is that the project site is also an active clinical site. Processes to improve quality
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in the center are ongoing and the census is not static, but rather subject to daily changes
in patient mix, which means that, a variety of uncontrolled variables could also be
potentially impacting outcomes.
Recommendations
This clinical change project was an important step toward measuring the impact and
evaluating the process of systematic implementation of CPG’s to reduce UTI and
improve UTI management in this rural southwestern Ohio LTC setting. The findings of
this project determined a marked improvement in compliance with critical elements of
the AMDA CPG: CI through use of a nursing-driven, evidence-based protocol. There was
an also clinically significant reduction in the overall incidence of UTI, antimicrobial
usage, and unplanned discharges related to URI/urosepsis. Recommendations for future
EBP application include:
•

Implementation in LTC centers that are in a variety of geographical locations to
determine the applicability to a variety of settings.

•

Measure of outcomes across a greater duration of time to gauge impact across time
and sustainability of interventions.

•

Development of additional tools for staff to use as reference for following AMDA
CPG: CI recommendations (i.e. poster with charting elements and criteria).
Summary
The project had a clinical problem trigger of UTI incidence greater than the national

benchmark and increased unplanned discharges related to UTI/urosepsis. The overall
project goal was to improve the quality of care of LTC residents through use of best
practices for the prevention and management of UTI. The Iowa Model of Evidence-based
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Practice was used to guide the project. Through an interdisciplinary team approach to
EBP. An assessment of internal and external data led to the identification of the PICOT
question: In patients living in a LTC facility (P), how does implementation of the AMDA
Clinical Guideline: Common Infections (AMDA CPG: CI) (I) compared to current
practices(C) affect urinary tract infection rates, antimicrobial usage, unplanned
discharges (O) over three months (T).
A systematic evaluation of current center practice compared to the AMDA CPG: CI
recommendations led to the project team development of a nursing-driven protocol for
sUTI recognition and management as an intervention to close the gaps between current
practice and best practice as defines by the CPG. The protocol was implemented in the
center and both outcome and process indicators were measured and analyzed. Incidence
of UTI, antimicrobial use, and unplanned discharges were reduced during the
intervention period though these were not statistically significant upon computation.
Process indicators supporting the evidence of compliance with AMDA CPG:CI
recommendations were also improved and these were statistically significant.
Dissemination of the project results is an important step in advancing future CPG
integration and evaluation in the LTC setting and is critical in promoting the clinical
practice doctorate in nursing (Melnyk & Fineout-Overholt, 2011). Abstracts for this
project have been submitted to the national Geriatric Advanced Practice Nurses’
Association (GAPNA) and the national DNP conference in 2015. A manuscript for
publication is also planned to disseminate the results of the project.
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Appendix A
Identified Barriers and Facilitators for EBP Change Project
Barriers

Action Plan

Need for staff/team buy-in and accountability
for utilizing EBP project process

Met with key stakeholders and discussed
proposed EBP Clinical Change Project in
relationship to quality, cost, and outcomes

Acceptance of EBP project process by medical
providers in the center

Worked through center Medical Director to
encourage acceptance and participation

Lack of history of culture of support for EBP
within the center
Sustainability of the CPG across shifts and
over time

Introduced EBP principles to the
Interdisciplinary Project Team and educated all
clinical staff on the project and basic EBP
principles
Targeted educational intervention to promote
compliance with the CPG

Historical limited engagement by professional
pharmacy and medical professionals in
quality improvement activities in the center.

APRN met individually with pharmacy
consultant and medical providers to provide
information about the project and gain buy-in
and commitment for participation
Facilitators
Action Plan
Currently established support from the center Continuous communication and update on
Administrator, nursing leadership and
project implementation schedule
Medical Director with the clinical problem
identified as an organizational priority
Administrator support for compensation of
staff/team members for team meeting time

Provided cost-benefit analysis to center
Administrator to provide support for rationale
of compensation for project time
Administrator communicated her support of
the project to staff

Medical director is familiar with AMDA
guidelines, is an active MADA member and
has expressed support for use of the AMDA
CPG: CI

Continuous communication and update on
project implementation schedule
Medical director communicated his support of
the project to staff and providers
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Appendix B
Search Strategy

Date of
Search
2/3/12
2/3/12

2/3/12

2/3/12

9/12/13

2/3/12

9/12/13

2/3/12
2/3/12
2/3/12
2/3/12

2/3/12

Keyword(s) used
UTI
UTI or Urinary Tract
Infection AND long term
care
UTI OR Urinary Tract
Infection AND LTC OR
Long Term Care
UTI OR Urinary Tract
Infection AND LTC OR
Long Term Care Plus
limits of EBP and
English articles only
UTI OR Urinary Tract
Infection AND LTC OR
Long Term Care Plus
limits of EBP and
English articles only plus
date range 2012-2013
Clinical Practice
Guidelines AND long
term care
Clinical Practice
Guidelines AND long
term care plus date range
2012-2013
UTI
Urinary Tract Infection
UTI or Urinary Tract
Infection
UTI or Urinary Tract
Infection AND long term
care

UTI or Urinary Tract
Infection AND long term
care OR LTC with limits
of: human, age 19+ years,
date range 1/01/200012/31/2012, clinical
trials, meta-analysis, rct,
practice guideline,
English, PLUS EBM

Database/Source
used
CINAHL
CINAHL

# of Hits Listed

# of Hits
Reviewed

# of Hits
Used

CINAHL

2157

CINAHL

62

62

2

CINAHL

15

15

3

CINAHL

9

9

6

CINAHL

10

10

1

PubMed(Medline)
PubMed(Medline)
PubMed(Medline)

8809
28,891
32,938

PubMed(Medline)

28,918

PubMed(Medline)

16

16

3

52

834
876

9/26/13

UTI or Urinary Tract
Infection AND long term
care OR LTC with limits
of: human, age 19+ years,
date range 12/31/20129/26/2013, clinical trials,
meta-analysis, rct,
practice guideline,
English, PLUS EBM

PubMed(Medline)

0

0

0

2/3/12

Clinical Practice
Guidelines AND Urinary
Tract Infections with
limits of: humans, aged
65+ years, English

PubMed(Medline)

47

47

2(same 2
as in
CINAHL)

9/26/13

Clinical Practice
Guidelines AND Urinary
Tract Infections with
limits of: humans, aged
65+ years, English

PubMed(Medline)

1

1

0

9/26/13

Urinary Tract
Infection(keyword) and
older adults or long term
care

Cochrane Library

3

3

1

53

# of Hits
Used

Appendix C
Evidence Included and Excluded with Rationale
Citation
First Author (Year)
Hooton, T. et al. Clinical
Infectious Diseases, 50,
625-663 (2010)

Gould, C. et al. HICPAC
(2010)

Citation
Title
Diagnosis, prevention, and
treatment of catheterassociated urinary tract
infection in adults: 2009
international clinical
practice guidelines from the
Infectious Diseases Society
of America
Guidelines for prevention
of catheter-associated
urinary tract infections
2009

Included/Excluded and
Rationale
Included- CPG related to
CAUTI with specific
considerations for LTC
included. This CPG is
included in the AMDA CPG:
CI.

Included- CPG for CAUTI
with comprehensive grading
of evidence for each
intervention. This CPG is not
included in AMDA CPG: CI
due to its release in late
2010.
Included- general CPG for
infection prevention in LTC,
includes recommendations
for UTI prevention. This
CPG is included in AMDA
CPG: CI.
Include- Intervention study
on education on treatment
guideline for UTI.

Smith, et al. American
Journal of Infection
Control, 36, 504535(2008)

SHEA/APIC guideline:
Infection prevention and
control in the long term
care facility

Deuster, S. et al. Journal
of Clinical Pharmacy and
Therapeutics, 35, 71-78.
(2010)
Genao, L. et al. Annals of
Long Term Care, 20(4),
33-38.

Implementation of
treatment guidelines to
support judicious use of
antibiotic therapy
Implementation of a UTI
Include-Intervention study on
algorithm to reduce
implementing clinical
inappropriate antibiotic
guidelines in LTC
treatment and rate of UTI in
LTC.

Citation
First Author (Year)
Woodford, H. Journal of
the American Geriatric
Society, 57, 107-114.
(2009)

Citation
Title
Diagnosis and management
of urinary tract infection in
hospitalized older people

54

Included/Excluded and
Rationale
Excluded- setting is acute
care

Juthani-Mehta, M., et al.
Journal of the American
Geriatric Society, 57, 963970. (2010)
Colon-Emeric, C. Journal
of the American Geriatrics
Society, 55, 1404-1409.
(2007)
Resnick, B., et al. Journal
of the American medical
Directors Association,
Jan-Feb, 1-8. (2004)
Wipke-Tevis, et al.
Jouranl of the American
Geriatric Society, 52, 583588. (2004)

Clinical features to identify
urinary tract infection in
nursing home residents: A
cohort study
Barriers to and facilitators
of clinical practice
guideline use in nursing
homes
Testing the feasibility of
implementation of clinical
practice guidelines in long
term care facilities
Nursing home quality and
pressure ulcer prevention
and management practices

Hutt, E, et al. Journal of
the American geriatric
Society, 54, 1694-1700.
(2006)

A multifaceted intervention
to implement guidelines
improved treatment of
nursing home acquired
pneumonia in a state
veteran’s home.
Clinical practice guidelines
in the nursing home.

Berlowitz, D. et al.
American Journal of
Medical Quality, 16, 189195.
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Included- this is a study that
supports the use clinical
criteria for accurate UTI
diagnosis.
Included- addresses potential
barriers and suggestions for
implementation of CPG
Included- provides qualitative
data regarding
implementation of CPG in
LTC.
Included- Provides a basis for
developing educational and
quality improvement
programs related to use of
CPG and quality in LTC.
Included- Demonstrates
effectiveness of evidencebased guidelines in
improving compliance with
current practice standards.
Included- Supports that
CPG’s are not systematically
implemented in nursing
homes.

Appendix D
Clinical Practice Guideline Appraisal Summary

Appraisal
Question
Who were the
CPG
developers?

Were the
developers
representatives
of key
stakeholders?
Who funded the
guideline
development?
Were any
guideline
developers
funded
researchers of
the reviewed
studies?

Appraisal
Question
Was an explicit,
sensible and
impartial
process used to

AMDA
CPG:CI
2011
AMDA

IDSA CAUTI
CPG 2009

CDC CAUTI
CPG 2009

SHEA/APIC
CPG 2008

IDSA in
collaboration
with American
Geriatrics
Society,
American
Society of
Nephrology,
American
Urological
Association
Y

HICPAC

SHEA/APIC

Y

Y

AMDA

U

U

U

Y

U

U

U

IDSA CAUTI
CPG 2009

CDC CAUTI
CPG 2009

SHEA/APIC
CPG 2008

Y

Y

U

Y

AMDA
CPG:CI
2011
Y
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select and
combine
evidence?
Did developers
carry out s
comprehensive,
reproducible
literature
review within
the past 12
months of its
publication?
Were all
important
options and
outcomes
considered?
Is each
recommendatio
n in the
guideline tagged
by level of
strength and
linked with
evidence?

Appraisal
Question
Has the
guideline been
subjected to
peer review and
testing?
Is the intent of
use provided?
Are
recommendatio
ns clinically
relevant?

Y

Y

Y

Y

Y

Y

Y

Y

Y
Y
Level of
evidence is not
graded or
explicitly
stated, but
each
recommendati
on is linked to
evidence.

Y

Y
Level of
evidence is not
stated. Data
from the
literature is
provided for
each
recommendatio
n.

AMDA
CPG:CI
2011
N

IDSA CAUTI
CPG 2009

CDC CAUTI
CPG 2009

SHEA/APIC
CPG 2008

U

U

U

Y

Y

Y

Y

Y

Y

Y

Y
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Will the
recommendatio
ns help me in
caring for my
patients?
Are the
recommendatio
ns
practical/feasibl
e?
Are the
recommendatio
ns a major
variation from
current
practice?

Appraisal
Question
Overall
Conclusions

Y

Y

Y

Y

Y

Y

Y

Y

N

N

N

N

IDSA CAUTI
CPG 2009

CDC CAUTI
CPG 2009

SHEA/APIC
CPG 2008

CPG has welldocumented
levels of
evidence to
support
recommendatio
ns, quality is
high

CPG is a
targeted SR of
CAUTI
literature,
strength and
quality of each
recommendati
on is provided,
gaps in
literature for
each
recommendati
on is also
noted.

This guideline
is not as explicit
as the others in
regard to
specific
recommendatio
ns. It does
provide a
comprehensive
literature review
and provides
consideration of
unique aspects
of LTC.

AMDA
CPG:CI
2011
The CPG is
evidencebased, has
expert
consensus,
quality is
good.

Y= yes; N= no; U= unknown
Form from Melnyk & Fineout-Overholt (2011).
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Appendix E
Synthesis of CPG in LTC Evidence
Study

Design

Sample

Outcome

Deuster, S. et al. Journal of Clinical
Pharmacy and Therapeutics, 35, 71-78.
(2010)

Before-After
Interventions
Study
Purpose: To
evaluate the
use of
treatment
guidelines to
improve
antibiotic
therapy.
SR
Purpose: To
assess
effectiveness
of different
interventions
which target
healthcare
professionals
or
organizations
to improve
adherence to
infection
control
guidelines on
device-related
infections

N= 100
Consecutive
patients chart
analysis
before and
after
intervention

Treatment
guidelines for
common
infections
occurring in
hospitalized
patients resulted
in significant
increase in
appropriate
antibiotic use
Insufficient
evidence to
determine which
interventions are
most effective at
changing
adherence
behavior.
Educational
interventions
involving more
than one active
element
considered worth
further
investigation.

Design
Qualitative
analysis

Sample
N= 35
Setting: four
community
nursing
homes

Flodgren, G., et al. Cochrane Database of
Systematic Reviews, 3,
DOI:10.1002/14651858.CD006559.pub2

Study
Colon-Emeric, C. Journal of the American
Geriatrics Society, 55, 1404-1409. (2007)

Purpose:
Identify
barriers to and
facilitators of
the diffusion
of CPG’s in
nursing homes

59

13 studies
included; one
cluster
randomized
controlled
trial and 12
interrupted
time series
studies.
Setting:
hospitals

Outcome
centers included
in the study
systematically
adopted CPG’s.
Most frequently
cited barriers
included:
CPG’s viewed as
checklists and not
individualized,
perceived conflict
with
patient/family

Wipke-Tevis, et al. Jouranl of the
American Geriatric Society, 52, 583-588.
(2004)

Retrospective
analysis
Purpose: to
measure
quality
indicator
scores and
describe
prevention and
treatment
practices in
LTC.

Study
Berlowitz, D. et al. American Journal of
Medical Quality, 16, 189-195.

Design
Survey
Purpose: To
determine
whether and
how clinical
practice
guidelines
were being
used in nursing
homes.
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N= 362
Setting:
nursing
homes in
Missouri

Sample
N=1065
Setting :
Veterans
Affairs
Nursing
Homes

goals, liited
facility resources,
lack of
communication
between providers
between shifts,
facility policies
that conflict with
CPG’s.
40% used
assessment tool
that was not
evidence based.
<13% used CPG.

Outcome
79% reported
familiarity with
CPG’s
<50% reported
adoption and use
of CPGs. CPG’s
are not
systematically
implemented in
nursing homes.

Appendix F
Literature Evaluation Table
Citation
First
Author
(year)
Hooton,
T. et al.
Clinical
Infectiou
s
Diseases,
50, 625663
(2010)
Gould,
C. et al.
HICPAC
(2010)

Concep
t-ual
Framework
None

Deuster,
S. et al.
Journal
of
Clinical
Pharmac
y and
Therapeu
tics, 35,
71-78.
(2010)

None

None

Design/Method

Sampl
e

Measur
ement

Data
Analysi
s

Findings

n/a

Variable
s with
Definitio
n
n/a

CPG from the
IDSA
Purpose: to
provide
recommendations
for the diagnosis,
prevention, and
treatment of
CAUTI in adults.
CPG from
HICPAC
Purpose: Develop
guideline for
CAUTI
Prevention based
on targeted
systematic review
of the best
available
evidence.

n/a

n/a

n/a

n/a

n/a

n/a

Strategies to
reduce the use
and duration of
urinary
catheterization
are most
effective at
reducing
CAUTI.
Surveillance to
ensure
appropriate
catheter use,
aseptic insertion,
and proper
maintenance are
necessary.
QI program with
attention to
infection control
and staff
education is
necessary to
reduce CAUTI.

Before-After
Interventions
Study
Purpose: To
evaluate the use of
treatment
guidelines to
improve antibiotic
therapy.

100
consec
utive
patient
s chart
analysi
s
before
and
after
interve
ntion

IV=
Treatmen
t
Guidelin
e
DV=
appropria
te
antibiotic
use

Appropr
iate
antibioti
c
use/com
pliance
with
treatmen
t
guidelin
e

Frequen
cy
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Treatment
guidelines for
common
infections
occurring in
hospitalized
patients resulted
in significant
increase in
appropriate
antibiotic use

Citation
First
Author
(year)
JuthaniMehta,
M., et al.
Journal
of the
American
Geriatric
Society,
57, 963970.
(2010)

Concept
-ual
Framework
None

Resnick,
B., et al.
Journal
of the
American
medical
Directors
Associati
on, JanFeb, 1-8.
(2004)

None

Design/Method

Sampl
e

Prospective,
observational
cohort study.
Purpose: identify
clinical features
associated with
bacteriuria plus
pyuria in noncatheterized
nursing home
patients with
clinically
suspected UTI.

N=
551

Quantitative single
group repeated
measure.
Qualitative
analysis.
Purpose: explore
the feasibility of
implementing two
specific AMDA
CPG’s

N= 40
faciliti
es

Setting
:5
Conne
cticut
nursin
g
homes

Setting
: LTC
in
Maryl
and
(23
centers
)

Variables
with
Definitio
n
UTI:
bacteriu
ria
(>100,00
0 CFU
accordin
g to
urine
culture)
plus
pyuria(>
10 white
blood
cells
accordin
g to
urinalysi
s.

Measure
ment

Data
Analysis

Findings

Combin
ed
outcom
e of
bacteri
uria
(>100,0
00 CFU
from
urine
culture)
and
pyuria
(>10
white
blood
cells
from,
urinaly
sis).

RR

Dysuria,
change in
mental status,
and and change
in character of
urine were
significantly
associated with
the combined
outcome of
bacteriuria
plus pyuria.

CPG
impleme
ntationdefined
by
process
indicator
s for each
CPG.

Process
indicato
rs of
CPG
impleme
ntation.

Frequen
cy

45% of facilities
actually
implemented at
least one CPG.
Four themes
emerged from
interview data:
Challenges to
implementations
,
Benefits of
implementation,
Process
recommendation
s,
Recommendatio
ns for changes
to CPG’s
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Intervie
ws.

Citation
First
Author
(year)
Berlowit
z, D. et
al.
America
n Journal
of
Medical
Quality,
16, 189195.

Concept
-ual
Framework
None

Design/Method

Sampl
e

Survey
Purpose: To
determine whether
and how clinical
practice guidelines
were being used in
nursing homes.

N=106
5
Setting
:
Vetera
ns
Affairs
Nursin
g
Homes

Variables
with
Definitio
n
Were
staff
familiar
with
clinical
practice
guideline
s?

Measure
ment

Data
Analysis

Findings

Were
staff
familiar
with
clinical
practice
guidelin
es?

Frequen
cy

79% reported
familiarity with
CPG’s

Did staff
report
impleme
ntation
and use
of
clinical
practice
guideline
s?

Did
staff
report
impleme
ntation
and use
of
clinical
practice
guidelin
es?
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<50% reported
adoption and use
of CPGs.

Appendix G
Evaluation Measures

Evaluation Component
Outcome Indicators
Incidence of UTI per 1000 resident
days
Incidence of unplanned discharges
from the center to acute care
facilities/ER for UTI/urosepsis
Incidence of antibiotic usage in
center
Process Indicators
Evidence of process for suspected UTI
risk
Evidence of suspected UTI assessment in compliance with AMDA CPG:
CI
Evidence of appropriate diagnostics
for suspected UTI in compliance with
AMDA CPG:CI
Evidence that residents with
suspected UTI being treated with
antimicrobial therapy meet criteria
for UTI
Evidence that appropriate
transmission precautions are
implemented for UTI caused by
MDRO’s.
Staff evaluation of intervention

Measurement Approach
System data for facility size and census
System data for facility size and census
System data from monthly pharmacy
report and retrospective chart audits
Included in the chart audit tool (developed
by project team)
Records reviewed for pre-intervention and
post-intervention (3month interval) using
chart audit tool.
Records reviewed for pre-intervention and
post-intervention (3month interval) using
chart audit tool
Records reviewed for pre-intervention and
post-intervention (3month interval) using
chart audit tool
Records reviewed for pre-intervention and
post-intervention (3month interval) using
chart audit tool
Focus group with nursing staff postintervention
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Appendix H
EBP Project Implementation and Evaluation Timeline
Activity
Step 1: Selection of a Topic
• Identification of problem trigger: Increased UTI and associated negative
patient outcomes
• Identify Stakeholders
• Identify barriers and facilitators and strategies for minimizing barriers
and maximizing facilitators
Step 2: Form a Team
• Determine team members and team roles
• Develop PICO question
Step 3: Evidence Retrieval
• Conduct literature search

Step 4: Grading the Evidence
• Complete appraisal of evidence
(Search Strategy, Data Extraction, and Evaluation of Evidence tables)

Step 5: Developing an Evidence-based Standard/Recommendation
• Define project purpose
• Define project outcome indicators of a successful project.
• Develop data collection protocol
• Develop process evaluation tool(s)
• Develop project-related products
• Develop evaluation plan
• Develop project economic analysis
• Complete presentation for dissemination of project initiation and educate
stakeholders on project progress to date
• Complete project proposal draft in NURS 7090
• Begin acquisition of necessary approvals (facility approval, IRB)
•
•

Revise project proposal and share with Project Chair

Arrange Initial Proposal Defense with Project Chair and Committee
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Timeline
Completed
December 2011

Completed
December 2011

Original literature
search completed
January-February
2012; updated
literature search
completed
September 2013.
Original
completed
January-February
2012; update
completed
September 2013.
December 2013

January-February,
2014
March-April, 2014

•
•

Finalize project proposal
Finalize necessary IRB approval and submit when committee approval
received
Step 6: Implementing the EBP Project
Phase I: Timeline and Baseline Data Collection
• Meet with team and discuss project timeline and inform stakeholders of
implementation date
- Develop formal schedule for implementation
• Complete baseline data collection of outcome indicators
• Complete process indicator evaluation
- This will be based on the AMDA CPG: CI and will involve a systematic
assessment of current practices in the center as they compare to the
CPG
- Complete baseline staff knowledge survey
Phase II: Design Clinical Change Intervention(s)
• Team will review baseline data and determine intervention where gaps
between practice and CPG exist.
• Intervention(s) will be planned based on this assessment
• This will include development of additional project products required for
the intervention(s) implementation and evaluation.
• Determine the “go live” date for intervention implementation

Phase III: Deploy Clinical Change Intervention(s)
• Complete formal education session(s) for intervention(s); this will
include instructions for use of any project products necessary for
intervention implementation
• “Go Live”
Step 7: Evaluation of the Clinical Change
• Complete outcome indicator evaluation
- Monitor incidence of UTI per 1000 resident days over 3 month period
following “go live” date
- Monitor incidence of unplanned discharges to acute care/ER for
diagnosis UTI/urospesis over 3 month period following ‘go live “ date
- Monitor antibiotic usage in center over 3 month period following “go
live” date.
•

•

Complete process indicator evaluation
- Evidence of process for suspected UTI risk
- Evidence of suspected UTI assessment in compliance CPG
- Evidence of appropriate diagnostics for suspected UTI in compliance
with AMDA CPG: CI
- Evidence that residents with suspected UTI being treated with
antimicrobial therapy meet criteria for UTI
- Evidence that appropriate transmission precautions are
implemented for UTI caused by MDRO’s
- Complete focus groups with nursing staff
Data Analysis Completion
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March-April, 2014

July 2014
September 2014
September 2014

September 2014

September 2014
October 2014
October 2014January 2015

February 2015

March 2015

Appendix I
Suspected Urinary Tract Infection Chart Audit Guidelines
Background
Infections are common in Long Term Care (LTC), represent a major source of morbidity and
mortality in LTC, and contribute significantly to unplanned discharges from LTC to acute
care settings. Urinary tract infections (UTI) are one of the most common infections in LTC
facilities.
Measure

This audit will determine the number of residents with suspected or diagnosed UTI in the
LTC facility who met the American Medical Director’s Association (AMDA) clinical practice
guideline (CPG) for common infections in LTC standards.
Instructions

This CPG-specific chart audit tool is derived from the AMDA CPG: Common Infections and
focuses on those aspects of the practice guideline pertaining to UTI. This tool is used to
document the review of source documents and CPG for agreement. Source documents are
original documents/data/records (i.e. clinic charts/notes, checklists, lab reports, diagnostic
reports, etc.).
For each subject reviewed:

1. Begin using this tool by completing the header information (name of site, name of
reviewer, date of review, review period).
2. For each section reviewed, check the appropriate boxes (‘N/A’, ‘Yes’, ‘No’). If the
‘No’ box is checked for any question, provide a description for each ‘No’ response in
the area provided within that section.
3. At the conclusion of the review, summarize findings in the Summary of Findings
section.
4. The reviewer signs and dates the Chart Audit Tool and files it within the UTI Chart
Audit binder.
Reference
American Medical Director’s Association (2011). Common infections in the long-term care
setting clinical practice guideline. Columbia, MD.
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Suspected UTI Chart Audit Tool

Site:____________________________________Review Date:_____________________

Reviewed by:____________________________Review Period:____________________
Inclusion Criteria: (please check appropriate box)

Diagnosis of UTI during review period
Antibiotic prescribed for UTI during review period
Urinalysis/urine culture performed during review period
If none of the above criteria are met, this chart is NOT eligible for this audit.
Exclusion Criteria:
None
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Suspected UTI Chart Audit Tool
Site:____________________________________Review Date:____________________ Review
Period:__________________________________________________________
Reviewed by: ____________________________________________________________

Element A: Recognition
Yes No n/a Comments
1. Presence of dysuria OR two (2) or more of
the following documented (Check those
that are documented).
Fever(100 degrees F or 2.4 degrees
above baseline)
Urinary frequency
Urinary urgency
Flank /suprapubic pain
Gross hematuria
New or worsened urinary
incontinence
Shaking chills/rigors
New onset of delirium
Element B: Assessment
2. Documentation of nursing history and
physical exam elements present at the
time of initial symptom(s)?
Physical assessment including body
temperature
Dipstick urine test results documented
Medical provider notified of resident
condition and symptoms
Urinalysis ordered
Urine culture completed:
Pathogen
identified:______________________________@>100,0
00 cfu’s
3. MDRO identified as causative organism by
culture?
4. If answer to item 3 was “yes”:
Evidence of contact transmission
precautions order present?
5. Patient transferred to an acute care
setting?
6. If answer to item 5 was “yes”:
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Yes

No

n/a

Comments

Evidence of at least one (1) of the following
are present in the record: Check those that
are documented as present.
Resident’s vital signs unstable and/or
family /patient requests transfer or
desire aggressive treatment.
Critical diagnostic tests are not
available in the facility during the
required time period.
Scope or intensity of required
monitoring or treatment is beyond
facility’s capacity.
Specific infection prevention/control
measures are not available in the
facility.
7. Evidence of ongoing monitoring
documented in the chart in regard to
resident response to treatment? (i.e. body
temperature, presence of clinical s/s
infection)
Element C: Treatment

Yes

1. Antipyretic administered for fever greater
than 100 degrees F?
2. Antibiotic therapy prescribed before urine
culture results were available?
Antibiotic
prescribed:______________________________
(please provide full Rx. Info including
drug, dose, route, frequency, and duration)
3. Urine culture negative?
4. If answer to item 10 was “yes” was
antibiotic therapy discontinued?
5. Antibiotic therapy prescribed based on
urine culture results?
Antibiotic
prescribed:______________________________
(please provide full Rx. Info including
drug, dose, route, frequency, and duration)
6. Antibiotic change indicated based on urine
culture results?
7. If answer to item 13 was “yes”, was a
change in antibiotic regime implemented?
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No

n/a Comment
s

Does the resident have any of the following? (Check those that apply)
__________Intermittent bladder catheterization
__________Indwelling foley catheter
__________Supra-pubic catheter
__________Ileoconduit device
If any of the above was checked, please list the diagnosis(es) associated with the
urinary
device:_________________________________________________________________________________________________
___

Summary of Review Findings:
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
____________________________________________________________________________________
Signature of Reviewer:___________________________________Date:______________
Reference

American Medical Director’s Association (2011). Common infections in the long-term care
setting clinical practice guideline. Columbia, MD.
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Appendix J

Suspected Urinary Tract Infection (SUTI) Protocol Worksheet
Patient Name:__________________________
Step 1: Does the patient have a change in condition that suggests UTI?
The patient has had a change in: (Please circle all that apply)
o
o
o
o
o
o
o
o
o
o
o
o
o

Vital signs: Temp, Resp rate, Pulse, BP
ADL performance
Food/fluid intake
Mental status
Skin temperature/color
Sleep pattern
Fall/balance/gait
Chills
Dizziness
Dysuria
Urinary frequency
Urinary incontinence (new or increased)
Hematuria

Step 2: Perform History and Physical Exam
• Vital Signs__________T_____________P_____________R________________BP
• Mental Status: __Alert___Lethargic___Confused___Other:_________________________________
• FSBS if patient is diabetic:______________
• Urinary Symptoms: ____dysuria______hematuria____ suprapubic/flank pain

_____ scrotal contents tenderness_____ bladder distention_____________other(please specify)

Obtain a urine specimen and perform dipstick urine test and record:
Date:___________Time:__________
Results: ___ Positive for leukocyte esterase/WBC (Send specimen for UA/C&S)
___ Negative for leukocyte esterase/WBC (Consult physician/PA/NP)
Determine if patient meets criteria for empiric antibiotic therapy:
•
•

Patients WITHOUT indwelling catheter (Must have at least 3)
Patients WITH indwelling catheter (Must have at least 2 )
 Fever greater than 100 F or chills/rigors
 New or increased dysuria, frequency, or urgency
 New flank/suprapubic pain/tenderness
 Change in character of urine
 Worsening mental or functional status (includes urinary
incontinence)

Does the patient meet criteria for empiric antibiotic therapy?
____Yes- proceed to Step 3 and anticipate empiric antibiotic therpay
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____No - proceed to Step 3 and anticipate ongoing infection surveillance
Nurse Initials:_________ Date:_________Time:__________

Step 3: Notification of Provider
Date:_______Time:________Provider:_______________
Patient condition warrants transfer to acute care?____Yes (Contact Physician/PA/NP) ____No
Further diagnostics ordered?___No___Yes:________________________________________________
Antibiotic therapy ordered?____No____Yes
* Communicate whether patient meets criteria for empiric antibiotic therapy

Nurse Initials:_________ Date:_________Time:__________

Step 4: Treat Symptoms of SUTI
• Encourage fluid intake (target goal of 1500 ml over next 24 hours unless contraindicated)
• Treat fever if it is:
a) Causing discomfort
b) Resulting in S/S of hemodynamic instability (pulse > 100 bpm, hypotension)
Step 5: Develop Individual Acute Care Plan
• Communicate to care team members

Nurse Initials:_________ Date:_________Time:__________

Step 6: Monitor Patient Response
• Assess and document every shift to include exam elements in Step 2
• Assess and document every shift response to treatment
• Report any deterioration or failure to respond to treatment to provider
• Communicate UA/urine culture results to provider

Step 7: Determine if Heighted Infection Control is Warranted
Urine culture results:_____________________________________________________
Is the causative agent identified by culture as a multi-drug resistant organism (MDRO)?
___No- Standard precautions
• Urine must be contained by patient continence, incontinence supplies, or catheter

___Yes- Contact Precautions
• Urine must be contained by patient continence, incontinence supplies, or catheter
• Order for Contact Precautions is written and implemented as appropriate
Nurse Initials:_________ Date:_________Time:__________
Step 8: Communication
Communicate the following to the care team:
• Patient status
• Any heightened Infection Control

Please place the SUTI Protocol Worksheet in the protocol binder once the culture report has been
received, reported, and noted above.

73

Reference

American Medical Directors Association (AMDA) (2011). Common Infections in the
Long term Care Setting Clinical Practice Guideline. Columbia, MD: AMDA
2011.
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Appendix K

Slide 1

PowerPoint for sUTI Protocol Education
Suspected Urinary Tract Infection
(SUTI) Protocol

An evidence-based approach to quality care in long term care

Slide 2
Infections in Long Term Care (LTC)
 Infections are a significant source of illness and death in
LTC.
 Infections account for ½ of all transfers to acute care
facilities from LTC
 Urinary tract infection (UTI) is one of the top 2 infections in
LTC
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Slide 3
An Evidence-based Approach
 The SUTI protocol has been developed by an
interdisciplinary team to address the gaps between
current facility practice and best practice.
 The American Medical Directors Association Clinical
Practice Guideline for Common Infection in LTC and HCF
Infection Control policies have been used to create the
protocol.
 The protocol is NURSING-DRIVEN!

Slide 4

Discuss asymptomatic bacteriuria
THE GOAL
 Reduce the incidence of UTI and urosepsis
 Reduce incidence of MDRO UTI
 Reduce unplanned discharges related to UTI
 Reduce antibiotic usage for asymptomatic bacteriuria

Slide 5
Step 1: Does the patient have a
change in condition that suggests
UTI?
Changes in:
Vital signs

Chills

ADL performance

Dizziness

Food/fluid intake

Dysuria

Mental status

Urinary frequency

Skin temperature/color

Urinary incontinence (new or
increased)

Sleep pattern
Fall/balance/gait

Hematuria

76

Slide 6
SUTI Worksheet

Full Worksheet will be distributed and
application reviewed.

Dipstick Urine

Will do demonstration/return demo of
dipstick urine test and interpretation

Slide 7

 This is a quick and efficient way to SCREEN for SUTI
 A POSITIVE result is one that reflects positive:
 Leukocytes
AND/OR
 Nitrites

 If a dipstick urine is positive, and
the patient has symptoms of SUTI
send the specimen to the
lab for UA/C&S

Slide 8
Urine Chemstrip Results
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Slide 9

Discuss role of nursing in assisting
antibiotic stewardship along with
providers.

To treat(empirically) or not to treat?
 Patients WITHOUT indwelling
catheter must have 3
 Patients With indwelling
catheter must have 2

 Fever greater than 100 F
OR chills/rigors
 New or increased dysuria,
frequency, or urgency
 New flank/suprapubic
pain/tenderness
 Change in character of
urine
 Worsening mental or
functional status (includes
urinary incontinence)

Slide 10
SUTI Worksheet

Slide 11
Step 3: Notification of Provider
 Does the patient’s condition warrant transfer to acute
care?
 The patient has unstable vital signs and the patient/family
desire aggressive intervention
 Required diagnostics are not available in an appropriate
time period
 The scope or intensity of monitoring are beyond the facility’s
capacity
 Patient/family request a transfer
* The physician/PA/NP must be notified of any impending
unplanned transfer to the hospital
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Slide 12

Discuss the evidence concerning
treatment of AB and infection
surveillance while awaiting culture
(many patients improve in this time).
Discuss antibiotic stewardship

Assisting the provider to make an
informed treatment decision
 Provide a clear, concise picture of the patient condition
 Communicate whether the patient meets criteria for
empiric SUTI treatment or not

Slide 13
SUTI Worksheet

Slide 14

Discuss contraindications to pushing
fluids.

Step 4: Treat Symptoms of SUTI
 Encourage fluid intake
 Target goal = 1500 ml over 24 hours unless contraindicated

 Treat fever if:
 It is causing discomfort
 There is hemodynamic instability
 Pulse >100 bpm
 hypotension
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Slide 15
SUTI Worksheet

Slide 16
Step 5: Develop an Individualized
Care Plan

Slide 17
SUTI Worksheet
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Slide 18
Step 6: Monitor Response
 Assessment and documentation every shift to include exam
elements in Step 2
 Assessment and documentation of response to treatment
(as appropriate)
 Report any deterioration or failure to respond to treatment
to provider (refer to Change in Condition Tool to determine
whether immediate vs. non-immediate notification is
appropriate)
 Communicate results of UA/C&S to provider
 If the culture is negative, any empiric
antibiotic therapy should be discontinued

Slide 19
Step 7: Determine if Heightened
Infection Control is Warranted
 Standard Precautions are applied to all patients at all
times
 Standard Precautions are acceptable for MOST SUTI’s
 Contact Precautions may be necessary if the causative
organism is a MDRO
 Urine must be contained by patient continence,
incontinence supplies, or catheter
 Order for Contact Precautions should be written and
implemented

Slide 20
SUTI Worksheet

81

Slide 21
Step 8: Communication
 Communicate the following to the care team:
 Patient status
 Any heightened infection control measures

Slide 22
SUTI Worksheet

Slide 23
Mrs. P
 Mrs. P is an 81 year old patient who was admitted 3 days
ago following a fall at home. She had no fractures but
multiple contusions and was in the hospital for 24 hours
prior to her admission here for rehab. She has DM2 and
OA.
 During your morning med pass Mrs. P tells you that she
has had some low back discomfort and feels nauseous
today. She ate <25% of breakfast. Her STNA reports that
she was incontinent of urine twice through the night
though she has been continent until now. VS: T=99.1,
P=84, R, 14, BP 126/76
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Slide 24

Does Mrs. P likely has a UTI?
Does she meet criteria for empiric
therapy?

 Your assessment reveals + suprapubic tenderness but no
distention. Mrs. P tells you that she has had to urinate 4-5
times this morning but “only go a little each time”.

You notify the physician and he orders
Levaquin 500 mg once daily x 7 days.
The urine is sent for culture.
After approx. 14 hours Mrs. P reports
she is feeling better.
The urine culture revelas >100,000 E.
coli which is sensitive to levofloxacin.

 Dipstick urine is + for nitrites and leukocytes and urine is
milky in appearance

Slide 25

What other assessment data might
you collect?
Could this patient have a SUTI?

Mrs. M
 Mrs. M is a 78 year old LTC patient at the center. She has
mild to moderate Alzheimer’s dementia and HTN. Her
daughter took her on an LOA to a family birthday party this
afternoon. Upon returning with Mrs. M to the center, Mrs. M’s
daughter reports that Mrs. M was confused and agitated
and refused to eat or drink anything during the outing and
she is concerned that something is wrong.

You decise to do watchful waiting for
Mrs. M and encourage fluids over the
evening and re-evaluate her . At
bedtime Mrs. .M. Exhibits no
agitation and seems more like her
usual. She is still afebrile and has no
localizing urinary symptoms. The next
morning she seems per her usual.

 When you assess Mrs. M you find that she is alert, mildly
agitated and more confused than her usual. VS: T= 97.4, R=
16, P= 74, BP= 116/70.
 The STNA toilets Mrs. M and reports that her urine is dark and
strong-smelling. She had no complaints of additional urinary
symptoms.

Slide 26
An ounce of prevention……
 Encourage adequate hydration
 Monitor personal hygiene of patients
 Use of appropriate incontinence products

 Toileting program
 Avoid or limit bladder catheterization when possible
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Slide 27
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